Skip to main content
SpringerLink
Log in

Melanomnachsorge: Welche Untersuchungen sind sinnvoll?

  • Chapter
Management des Melanoms

Part of the book series: Onkologie aktuell ((ONKAKTUELL))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Anonymus (1995a) Conférence de consensus. Suivi des patients opérés d’un mélanome de stade I. Ann Dermatol Venereol 122:250–258

    Google Scholar 

  • Ardizzoni A, Grimaldi A, Repetto L, Bruzzone M, Sertoli MR, Rosso R (1987) Stage I-II melanoma: the value of metastatic work-up. Oncology 44: 87–89

    Article  PubMed  CAS  Google Scholar 

  • Basseres N, Grob JJ, Richard MA, Thirion X, Zarour H, Noe C, Collet VA, Lota I, Bonerandi JJ (1995) Cost-effectiveness of surveillance of stage I melanoma. A retrospective appraisal based on a 10-year experience in a dermatology department in France. Dermatology 191: 199–203

    PubMed  CAS  Google Scholar 

  • Berman C, Reintgen D (1993) Radiologic imaging in malignant melanoma: a review. Semin Surg Oncol 9: 232–238

    PubMed  CAS  Google Scholar 

  • Blaheta HJ, Ellwanger U, Schittek B, Sotlar K, Maczey E, Breuninger H, Thelen MH, Bueltmann B, Rassner G, Garbe C (2000) Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol 114:637–42

    Article  PubMed  CAS  Google Scholar 

  • Blum A, Schlagenhauff B, Stroebel W, Breuninger H, Rassner G, Garbe C (2000) Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma: results of a prospective study of 1288 patients. Cancer 88: 2534–2539

    Article  PubMed  CAS  Google Scholar 

  • Brand CU, Ellwanger U, Stroebel W, Meier F, Schlagenhauff B, Rassner G, Garbe C (1997) Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors. Cancer 79: 2345–2353

    Article  PubMed  CAS  Google Scholar 

  • Buzaid AC, Sandler AB, Mani S, Curtis AM, Poo WJ, Bolognia JL, Ariyan S (1993) Role of computed tomography in the staging of primary melanoma. J Clin Oncol 11: 638–643

    PubMed  CAS  Google Scholar 

  • Buzaid AC, Tinoco L, Ross MI, Legha SS, Benjamin RS (1995) Role of computed tomography in the staging of patients with local-regional metastases of melanoma. J Clin Oncol 13: 2104–2108

    PubMed  CAS  Google Scholar 

  • Curry BJ, Myers K, Hersey P (1998) Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment, and recurrence from melanoma. J Clin Oncol 16: 1760–1769

    PubMed  CAS  Google Scholar 

  • Curry BJ, Smith MJ, Hersey P (1996) Detection and quantitation of melanoma cells in the circulation of patients. Melanoma Res 6:45–54

    PubMed  CAS  Google Scholar 

  • Dummer R, Panizzon R, Bloch PH, Burg G (2005) Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology 210: 39–44

    Article  PubMed  CAS  Google Scholar 

  • Finck SJ, Giuliano AE, Morton DL (1983) LDH and melanoma. Cancer 51: 840–843

    Article  PubMed  CAS  Google Scholar 

  • Garbe C (1996) Verlängertes Überleben bei fernmetastasiertem Melanom und der Einfluss von Behandlungen: Analyse des Krankheitsverlaufs von 22 Patienten mit einer Überlebenszeit von zwei Jahren und länger. Hautarzt 47: 35–43

    Article  PubMed  CAS  Google Scholar 

  • Garbe C (1997) Epidemiologie des Hautkrebses. In: Garbe C, Dummer R, Kaufmann R, Tilgen W (Hrsg) Dermatologische Onkologie. Springer, Berlin Heidelberg New York, Tokio, S 40–56

    Google Scholar 

  • Garbe C (2005) Cutaneous melanoma: baseline and ongoing laboratory evaluation. Dermatol Ther 18: 413–421

    Article  PubMed  Google Scholar 

  • Garbe C, Blum A (2001) Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 14:280–290

    Article  PubMed  CAS  Google Scholar 

  • Garbe C, McLeod GR, Buettner PG (2000) Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 89: 1269–1278

    Article  PubMed  CAS  Google Scholar 

  • Garbe C, Leiter U, Ellwanger U, Blaheta HJ, Meier F, Rassner G, Schittek B (2003a) Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients. Cancer 97: 1737–1745

    Article  PubMed  CAS  Google Scholar 

  • Garbe C, Paul A, Kohler-Späth H, Ellwanger U, Stroebel W, Schwarz M, Schlagenhauff B, Meier F, Schittek B, Blaheta HJ, Blum A, Rassner G (2003b) Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: Recommendations for an effective follow-up strategy. J Clin Oncol 21: 520–529

    Article  PubMed  Google Scholar 

  • Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R (2005) Deutsche Leitlinie: Malignes Melanom. In: Garbe C (Hrsg) Interdisziplinäre Leitlinien zur Diagnostik und Behandlung von Hauttumoren. Thieme, Stuttgart New York, S 23–55

    Google Scholar 

  • Gläser R (1997) Tumormarker des malignen Melanoms. In: Garbe C, Dummer R, Kaufmann R, Tilgen W (eds) Dermatologische Onkologie. Springer, Berlin, Heidelberg, New York, Tokio: 324–329

    Google Scholar 

  • Gläser R, Rass K, Seiter S, Hauschild A, Christophers E, Tilgen W (1997) Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study. J Clin Oncol 15:2818–2825

    PubMed  Google Scholar 

  • Guo HB, Stoffel WB, Bierwirth T, Mezger J, Klingmüller D (1995) Clinical significance of serum S100 in metastatic malignant melanoma. Eur J Cancer 31A: 1898–1902

    Article  PubMed  CAS  Google Scholar 

  • Häffner AC, Garbe C, Burg G, Büttner P, Orfanos CE, Rassner G (1992) The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients. Br J Cancer 66:856–861

    PubMed  Google Scholar 

  • Hauschild A, Engel G, Brenner W, Gläser R, Mönig H, Henze E, Christophers E (1999a) S100B protein detection in serum is a significant prognostic factor in metastatic melanoma. Oncology 56:338–344

    Article  PubMed  CAS  Google Scholar 

  • Hauschild A, Michaelsen J, Brenner W, Rudolph P, Gläser R, Henze E, Christophers E (1999b) Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients. Melanoma Res 9: 155–161

    Article  PubMed  CAS  Google Scholar 

  • Henze G, Dummer R, Joller JH, Böni R, Burg G (1997) Serum S 100-a marker for disease monitoring in metastatic melanoma. Dermatology 194: 208–212

    PubMed  CAS  Google Scholar 

  • Hofmann U, Szedlak M, Rittgen W, Jung EG, Schadendorf D (2002) Primary staging and follow-up in melanoma patients — monocenter evaluation of methods, costs and patient survival. Br J Cancer 87: 151–157

    Article  PubMed  CAS  Google Scholar 

  • Iscoe N, Kersey P, Gapski J, Osoba D, From L, DeBoer G, Quirt I (1987) Predictive value of staging investigations in patients with clinical stage I malignant melanoma. Plast Reconstr Surg 80: 233–239

    PubMed  CAS  Google Scholar 

  • Johnson TM, Bradford CR, Gruber SB, Sondak VK, Schwartz JL (2004) Staging workup, sentinel node biopsy, and follow-up tests for melanoma: update of current concepts. Arch Dermatol 140: 107–113

    Article  PubMed  Google Scholar 

  • Johnson TM, Fader DJ, Chang AE, Yahanda A, Smith JW, Hamlet KR, Sondak VK (1997) Computed tomography in staging of patients with melanoma metastatic to the regional nodes. Ann Surg Oncol 4: 396–402

    Article  PubMed  CAS  Google Scholar 

  • Keilholz U, Willhauck M, Rimoldi D, Brasseur F, Dummer W, Rass K, de Vries T, Blaheta J, Voit C, Lethe B, Burchill S (1998) Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC Melanoma Cooperative Group. Eur J Cancer 34: 750–753

    Article  PubMed  CAS  Google Scholar 

  • Kersey PA, Iscoe NA, Gapski JA, Osoba D, From L, DeBoer G, Quirt IC (1985) The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma. Br J Surg 72: 614–617

    PubMed  CAS  Google Scholar 

  • Khansur T, Sanders J, Das SK (1989) Evaluation of staging workup in malignant melanoma. Arch Surg 124: 847–849

    PubMed  CAS  Google Scholar 

  • Kluetz PG, Meltzer CC, Villemagne VL, Kinahan PE, Chander S, Martinelli MA, Townsend DW (2000) Combined PET/CT Imaging in Oncology. Impact on Patient Management. Clin Positron Imag 3: 223–230

    Article  Google Scholar 

  • Kuvshinoff BW, Kurtz C, Coit DG (1997) Computed tomography in evaluation of patients with stage III melanoma. Ann Surg Oncol 4: 252–258

    Article  PubMed  CAS  Google Scholar 

  • Meier F, Will S, Ellwanger U, Schlagenhauff B, Schittek B, Rassner G, Garbe C (2002) Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol 147:62–70

    Article  PubMed  CAS  Google Scholar 

  • Muller-Horvat C, Radny P, Eigentler TK, Schafer J, Pfannenberg C, Horger M, Khorchidi S, Nagele T, Garbe C, Claussen CD, Schlemmer HP (2006) Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma. Eur J Cancer 42: 342–350

    Article  PubMed  Google Scholar 

  • NIH (1992a) Diagnosis and treatment of early melanoma. NIH Consensus Development Conference. January 27–29, 1992. Consens Statement 10: 1–25

    Google Scholar 

  • NIH (1992b) NIH Consensus conference. Diagnosis and treatment of early melanoma. JAMA 268: 1314–1319

    Article  Google Scholar 

  • Orfanos CE, Jung EG, Rassner G, Wolff HH, Garbe C (1994) Stellungnahme und Empfehlungen der Kommission malignes Melanom der Deutschen Dermatologischen Gesellschaft zur Diagnostik, Behandlung und Nachsorge des malignen Melanoms der Haut. Stand 1993/94. Hautarzt 45: 285–291

    Article  PubMed  CAS  Google Scholar 

  • Prayer L, Winkelbauer H, Gritzmann N, Winkelbauer F, Helmer M, Pehamberger H (1990) Sonography versus palpation in the detection of regional lymph-node metastases in patients with malignant melanoma. Eur J Cancer 26: 827–830

    Article  PubMed  CAS  Google Scholar 

  • Provost N, Marghoob AA, Kopf AW, DeDavid M, Wasti Q, Bart RS (1997) Laboratory tests and imaging studies in patients with cutaneous malignant melanomas: a survey of experienced physicians. J Am Acad Dermatol 36: 711–720

    Article  PubMed  CAS  Google Scholar 

  • Rümke P, van-Everdingen JE (1992) Consensus on the management of melanoma of the skin in The Netherlands. Dutch Melanoma Working Party. Eur J Cancer 28: 600–604

    Article  PubMed  Google Scholar 

  • Salopek TG, Marghoob AA, Slade JM, Rao B, Rigel DS, Kopf AW, Bart RS (1995) An estimate of the incidence of malignant melanoma in the United States. Based on a survey of members of the American Academy of Dermatology. Dermatol Surg 21: 301–305

    Article  PubMed  CAS  Google Scholar 

  • Schittek B, Blaheta HJ, Flörchinger G, Sauer B, Garbe C (1999a) Increased sensitivity for the detection of melanoma cells in peripheral blood by an improved reverse transcription-polymerase chain reaction protocol. Br J Dermatol 141: 37–43

    Article  PubMed  CAS  Google Scholar 

  • Schittek B, Bodingbauer Y, Ellwanger U, Blaheta HJ, Garbe C (1999b) Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with prognosis. Br J Dermatol 141:30–36

    Article  PubMed  CAS  Google Scholar 

  • Schlemmer HP, Schafer J, Pfannenberg C, Radny P, Korchidi S, Muller-Horvat C, Nagele T, Tomaschko K, Fenchel M, Claussen CD (2005) Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system: initial experiences. Invest Radiol 40: 64–71

    Article  PubMed  Google Scholar 

  • Shivers S, Alsarraj M, Guiliano R, Jakub J, Pendas S, Reintgen D (2004) Molecular staging of melanoma. Ann Surg Oncol 11: 953–954

    Article  PubMed  Google Scholar 

  • Shivers SC, Wang X, Li W, Joseph E, Messina J, Glass LF, DeConti R, Cruse CW, Berman C, Fenske NA, Lyman GH, Reintgen DS (1998) Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA 280: 1410–1415

    Article  PubMed  CAS  Google Scholar 

  • Stadelmann WK, Rapaport D. P., Soong SJ, Reintgen DS, Buzaid AC, Balch CM (1998) Prognostic clinical and pathologic features. In: Balch CM, Houghton AN, Sober AJ, Soong SJ (eds) Cutaneous melanoma. Quality Medical Publishing, St. Luis, pp 11–50

    Google Scholar 

  • Terhune MH, Swanson N, Johnson TM (1998) Use of chest radiography in the initial evaluation of patients with localized melanoma. Arch Dermatol 134: 569–572

    Article  PubMed  CAS  Google Scholar 

  • Weiss M, Loprinzi CL, Creagan ET, Dalton RJ, Novotny P, O’Fallon JR (1995) Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas. JAMA 274: 1703–1705

    Article  PubMed  CAS  Google Scholar 

  • Yap JT, Carney JP, Hall NC, Townsend DW (2004) Image-guided cancer therapy using PET/CT. Cancer J 10: 221–233

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitäs-Hautklinik Tübingen, Liebermeister-Str. 25, 72076, Tübingen

    Garbe Claus (Prof. Dr. med.)

Authors
  1. Garbe Claus
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Claus, G. (2006). Melanomnachsorge: Welche Untersuchungen sind sinnvoll?. In: Management des Melanoms. Onkologie aktuell. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-28988-7_34

Download citation

  • DOI: https://doi.org/10.1007/3-540-28988-7_34

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-28987-6

  • Online ISBN: 978-3-540-28988-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation